Royal Philips has launched the Philips ECG AI Marketplace, which gives cardiac care teams access to multiple vendor offerings in one central location. The company hopes this can help clinicians efficiently manage and implement artificial intelligence (AI) technologies into their daily workflows.
New Philips platform offers AI-powered ECG tools from outside vendors
Related Articles
Anumana Secures FDA Clearance for First-of-Its-Kind ECG-AI Algorithm for Early Detection of Pulmonary Hypertension
CAMBRIDGE, Mass. – March 28, 2026 – Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled…{post_date: F d, Y}
AI algorithm for detection of cardiac amyloidosis gains FDA breakthrough device status
Healio: Anumana announced it received FDA breakthrough device designation for its artificial intelligence-guided ECG algorithm for the early identification of cardiac amyloidosis.{post_date: F d, Y}
AI-powered device to identify low LV ejection fraction gains FDA 510(k) clearance
Healio: An AI-powered device to identify low left ventricular ejection fraction in patients at risk for HF gained 510(k) clearance from the FDA.{post_date: F d, Y}
Anumana: Interview With CEO Maulik Nanavaty About The AI-Driven Health Technology Company
Anumana is a company that is harnessing industry-leading AI and translational science to decode electrical signals from the heart as never before, empowering healthcare providers to transform patient care throughout…{post_date: F d, Y}